Xeris Pharmaceuticals | XERS - Собственный капитал и резервы

Биржевая цена
5.81
Изменение за день
-0.23 -3.81%
Ежемесячно
-16.52%
Ежегодный
37.03%
Q1 прогноз
5.63




Собственный капитал и резервы Изменить Дата
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 546.45M 243.38M 2025-09
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 349.13M 36.37M 2025-09
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pharma Mar EUR 251.83M 54.32M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Tilray USD 1.51B 1.22B 2025-03
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09